Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients
Older patients with cancer, particularly those over 75 years of age, often experience poorer clinical outcomes compared to younger patients. This can be attributed to age-related comorbidities, weakened immune function, and reduced tolerance to treatme…